Zynerba Pharmaceuticals Inc

NASDAQ:ZYNE  
3.20
-0.14 (-4.19%)
4:07:40 PM EDT: $3.20 0.00 (0.00%)
Other Pre-Announcement

Zynerba Pharmaceuticals Q3 Loss Per Share $0.26

Published: 11/15/2021 12:24 GMT
Zynerba Pharmaceuticals Inc (ZYNE) - Zynerba Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Highlights.
Q3 Loss per Share $0.26.
Cash Runway Well Into First Half of 2024; $75.6 Million at September 30, 2021.
Q3 Earnings per Share View $-0.25 -- Refinitiv Ibes Data (analyst estimates).